Literature DB >> 9547261

The pro-oligonucleotide approach: solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates.

G Tosquellas1, K Alvarez, C Dell'Aquila, F Morvan, J J Vasseur, J L Imbach, B Rayner.   

Abstract

A modified phosphoramidite method has been designed for the solid-phase synthesis of two dodecathymidine phosphotriesters and two dodecathymidine thionophosphotriesters. In these analogs, each internucleoside link bears an S -acyl-2-thioethyl (Me-SATE or tBu-SATE) group removable upon esterase activation. Efficient synthesis of these lipophilic analogs was achieved thanks to the use of a photolabile linker anchored to the solid support in combination with thymidine-3'- O -phosphoramidites having a SATE group in place of the regular 2-cyanoethyl one. Both dodecathymidine phosphotriester and thionophosphotriester having S -acetyl-2-thioethyl groups were found to be stable in the presence of snake venom and calf spleen phosphodiesterases whereas, upon incubation in CEM cell extracts, they were selectively hydrolyzed to the anionic parent dodecathymidylate and dodecathymidine phosphorothioate, respectively. In addition, Me-SATE-protected dodecathymidine thionophosphotriester was stable in mouse and human sera as well as in human gastric juice. These results depict the potential of SATE-protected oligonucleotides as prodrugs of antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547261      PMCID: PMC147525          DOI: 10.1093/nar/26.9.2069

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  7 in total

1.  Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Authors:  S T Crooke; M J Graham; J E Zuckerman; D Brooks; B S Conklin; L L Cummins; M J Greig; C J Guinosso; D Kornbrust; M Manoharan; H M Sasmor; T Schleich; K L Tivel; R H Griffey
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

Review 2.  The esterases: perspectives and problems.

Authors:  W N Aldridge
Journal:  Chem Biol Interact       Date:  1993-06       Impact factor: 5.192

Review 3.  Pharmacokinetics of oligonucleotides.

Authors:  S Agrawal; R Zhang
Journal:  Ciba Found Symp       Date:  1997

4.  Structural characterization of three aldobiuronic acids derived from the capsular polysaccharide produced by the thermophilic cyanobacterium Mastigocladus laminosus.

Authors:  V Gloaguen; Y Plancke; G Strecker; L Vebret; L Hoffmann; H Morvan
Journal:  Int J Biol Macromol       Date:  1997-08       Impact factor: 6.953

5.  Oxalyl-CPG: a labile support for synthesis of sensitive oligonucleotide derivatives.

Authors:  R H Alul; C N Singman; G R Zhang; R L Letsinger
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

6.  Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver.

Authors:  R Mentlein; E Heymann
Journal:  Biochem Pharmacol       Date:  1984-04-15       Impact factor: 5.858

7.  Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate.

Authors:  I Lefebvre; C Périgaud; A Pompon; A M Aubertin; J L Girardet; A Kirn; G Gosselin; J L Imbach
Journal:  J Med Chem       Date:  1995-09-29       Impact factor: 7.446

  7 in total
  6 in total

1.  Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.

Authors:  Bryan R Meade; Khirud Gogoi; Alexander S Hamil; Caroline Palm-Apergi; Arjen van den Berg; Jonathan C Hagopian; Aaron D Springer; Akiko Eguchi; Apollo D Kacsinta; Connor F Dowdy; Asaf Presente; Peter Lönn; Manuel Kaulich; Naohisa Yoshioka; Edwige Gros; Xian-Shu Cui; Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

Review 2.  Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids.

Authors:  Arnaud Gissot; Michel Camplo; Mark W Grinstaff; Philippe Barthélémy
Journal:  Org Biomol Chem       Date:  2008-03-05       Impact factor: 3.876

3.  2'-O-(N-(Aminoethyl)carbamoyl)methyl Modification Allows for Lower Phosphorothioate Content in Splice-Switching Oligonucleotides with Retained Activity.

Authors:  Dmytro Honcharenko; Cristina S J Rocha; Karin E Lundin; Jyotirmoy Maity; Stefan Milton; Ulf Tedebark; Merita Murtola; Malgorzata Honcharenko; Andis Slaitas; C I Edvard Smith; Rula Zain; Roger Strömberg
Journal:  Nucleic Acid Ther       Date:  2022-03-02       Impact factor: 4.244

4.  Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs.

Authors:  Andrzej Grajkowski; Joao Pedras-Vasconcelos; Vivian Wang; Cristina Ausín; Sonja Hess; Daniela Verthelyi; Serge L Beaucage
Journal:  Nucleic Acids Res       Date:  2005-06-21       Impact factor: 16.971

Review 5.  Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing.

Authors:  Françoise Debart; Christelle Dupouy; Jean-Jacques Vasseur
Journal:  Beilstein J Org Chem       Date:  2018-02-19       Impact factor: 2.883

6.  On the stability of peptide nucleic acid duplexes in the presence of organic solvents.

Authors:  Anjana Sen; Peter E Nielsen
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.